These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2569073)

  • 1. Response to hepatitis B vaccine in infants born to mothers with schistosomiasis.
    Ghaffar YA; Kamel M; el-Sobky M; Bahnasy R; Strickland GT
    Lancet; 1989 Jul; 2(8657):272. PubMed ID: 2569073
    [No Abstract]   [Full Text] [Related]  

  • 2. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers.
    Farmer K; Gunn T; Woodfield DG
    N Z Med J; 1987 Jul; 100(827):412-4. PubMed ID: 2967932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis B screening in pregnancy and simultaneous postpartum vaccination of newborn infants].
    Sacher M
    Padiatr Padol; 1990; 25(2):111-5. PubMed ID: 2141397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis B virus infection and pregnancy: diagnostic screening and immune prevention].
    Gerken G; Meyer zum Büschenfelde KH
    Gynakologe; 1991 Jun; 24(3):125-8. PubMed ID: 1832653
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg.
    Pongpipat D; Suvatte V; Assateerawatts A
    Asian Pac J Allergy Immunol; 1986 Jun; 4(1):33-6. PubMed ID: 3730058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of hepatitis B by vaccination in 53 children at risk. Transmission of hepatitis B virus infection and its prevention].
    Zecca G; Motti G; Manzoni C; Del Curto E
    Minerva Pediatr; 1985 Sep; 37(17):593-6. PubMed ID: 2934613
    [No Abstract]   [Full Text] [Related]  

  • 8. [How infants of hepatitis B-positive mothers are protected].
    Pohjanpelto P
    Duodecim; 1989; 105(10):883-5. PubMed ID: 2527737
    [No Abstract]   [Full Text] [Related]  

  • 9. [Perinatal transmission of the hepatitis B virus and its prevention].
    Stránský J
    Cesk Pediatr; 1989 Nov; 44(11):658-60. PubMed ID: 2534508
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers.
    Lo KJ; Tsai YT; Lee SD; Wu TC; Wang JY; Chen GH; Yeh CL; Chiang BN; Yeh SH; Goudeau A
    J Infect Dis; 1985 Oct; 152(4):817-22. PubMed ID: 2931490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine.
    Pongpipat D; Suvatte V; Assateerawatts A
    Asian Pac J Allergy Immunol; 1989 Jun; 7(1):37-40. PubMed ID: 2526633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new program for provision of hepatitis B vaccine to neonates of HBsAg+ mothers.
    Colo Med; 1989 Apr; 86(8):125. PubMed ID: 2523271
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative evaluation of active and passive-active immunization of newborn infants born to mothers with HBV infection].
    Gładysz A; Inglot M; Molin I; Zalewska M; Maszkiewicz W; Patkowska B
    Przegl Epidemiol; 1991; 45(4):311-4. PubMed ID: 1841408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates.
    Assateerawatt A; Tanphaichitr VS; Suvatte V; In-ngarm L
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):89-93. PubMed ID: 1839654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B vaccine in neonates: induction of anti-HBs immune response and interruption of maternal HBsAg transmission.
    Wang YJ; Kang Y; Gong ZL; Mei YX; Xu JY; Meng LX; Zhao K; Li X; Hu ZH; Song ZZ
    Chin Med J (Engl); 1985 Apr; 98(4):265-70. PubMed ID: 3924520
    [No Abstract]   [Full Text] [Related]  

  • 16. Maternal-neonatal transmission of hepatitis B virus. Epidemiology and prevention.
    Zanetti AR
    Ann Ist Super Sanita; 1987; 24(2):277-84. PubMed ID: 2969205
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimal dose (1.25 micrograms) hepatitis B vaccine for infants and newborn babies, 4 years later.
    Scaravelli C; Bianchi E; Biraghi V; Calligari GC; Mariani G; Lucchesi P; DeLeo G
    Lancet; 1988 Jan; 1(8577):121. PubMed ID: 2891963
    [No Abstract]   [Full Text] [Related]  

  • 18. Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers.
    Belloni C; Orsolini P; Soldini L; Campisi D; Chiesa A; Ciceri R; Filice G
    Microbiologica; 1991 Jul; 14(3):195-8. PubMed ID: 1833611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis B--also a partner infection].
    Frösner GG
    Gynakologe; 1985 Sep; 18(3):151-5. PubMed ID: 2932378
    [No Abstract]   [Full Text] [Related]  

  • 20. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.